Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase 1 gamma 2 pseudogene 1 (CSNK1G2P1) is a pseudogene of the casein kinase 1 gamma 2 protein kinase gene. Pseudogenes are genomic copies of genes that typically harbor mutations preventing them from being translated into a functional protein. CSNK1G2P1 does not encode an active kinase or protein product, and therefore does not serve as a therapeutic target. While some pseudogenes may exert regulatory effects at the RNA level, no such function has been established for CSNK1G2P1. The canonical functional protein related to this pseudogene is **casein kinase 1 gamma 2 (CSNK1G2)**, which is a serine/threonine kinase involved in Wnt signaling and other cellular processes[1][5][3][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein kinase 1 gamma 2 pseudogene 1 (CSNK1G2P1).